IdeS: a bacterial proteolytic enzyme with therapeutic potential
Materials are managed with an emphasis on quality standards, recordkeeping, and research-use compliance
People with active cancer should consult their oncologist before using any immunomodulatory peptide, including Ta1 (despite its use in cancer immunotherapy in some countries) and BPC-157 (due to angiogenesis promotion)
No primary-prevention trial has yet shown that treating healthy adults to apoB below 0.6 g/L, for example, produces better outcomes than current practice
In addition, mitochondria modulate intracellular calcium homeostasis and immune regulatory pathways (420, 421), which means these pathways may too be compromised in ME/CFS
Consequently, the aforementioned data suggest that particular pathways may have both local and systemic relevance